Testing CARES, an integrated screening and stepped-care program, versus standard care in cancer clinics
Official title: Hybrid Type I Effectiveness-Implementation Cluster Randomized Trial of CARES
Run by University of Pittsburgh · NCT07183527 · Data updated 2026-11-12
This trial will test whether CARES helps adults with cancer reduce pain, fatigue, and depression and start treatment more often than standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1750 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | August 8, 2025 |
| Main results expected | January 10, 2030 |
| Study ends | January 31, 2030 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT07183527 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a cancer diagnosis who can read and write English and who do not have active psychosis or suicidal ideation are the ideal candidates for this trial.
✕Probably not a fit
Patients with evidence of thought disorder, delusions, hallucinations, active suicidal ideation with a plan, children, or those who cannot read/write English may not be eligible or likely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
CARES is an integrated screening and stepped collaborative care intervention designed to identify and treat depression, pain, and fatigue in people with cancer. In a pragmatic, cluster-randomized, hybrid type I effectiveness-implementation design, cancer clinics are randomized to offer CARES or continue standard care while investigators measure patient outcomes, implementation barriers and facilitators, and costs. Eligible participants are adults (≥18) with a cancer diagnosis who can read and write English, with exclusions for active psychosis or suicidal ideation with a plan. The trial includes a RE-AIM–guided implementation process evaluation and a full cost-effectiveness analysis to prepare for broader dissemination.
Why it matters
Potential benefit: If successful, CARES could increase treatment initiation, improve quality of life and symptom burden, reduce emergency care and hospital use, and lower overall healthcare costs.
How similar studies have gone: Prior research of CARES found 75% versus 4% treatment initiation compared with standard care, plus improvements in quality of life, symptoms, and substantial healthcare cost savings, supporting real-world testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Cancer * Age 18 years or older * Read and write in English Exclusion Criteria: * Evidence of thought disorder * Evidence of delusions * Evidence of hallucinations * Evidence of suicidal ideation with a plan
Where it's running
-
University of Pittsburgh Medical Center (UPMC) Cancer Center
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Jennifer L Steel, PhD — University of Pittsburgh
- Study coordinator: Jennifer L Steel, PhD
- Email: Steejl@upmc.edu
- Phone: 14126922041
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Imaging Mitochondrial Complex-I and Brain Metabolism in Alcohol Use Disorder
This study tests whether PET imaging with [18F]BCPP-EF and [18F]FDG can reveal differences in brain energy use between adults with alcohol use disorder and healthy controls, and whether these measures relate to relapse risk.
-
Imaging Brain Mitochondrial Complex-I in Cocaine Use Disorder
This study uses a PET scan with [F-18]BCPP-EF to see how mitochondrial Complex-I activity in the brain differs between people with cocaine use disorder and healthy controls.
-
Managing nighttime voiding in older women with sleep strategies
This study tests whether brief behavioral sleep therapy and mindfulness, alone or together, reduce how often older women wake at night to urinate and how much urine they produce at night.
-
Personalized pain relief for knee OA using central nervous system-based duloxetine
This study tests whether duloxetine can improve walking and daily activity in people with knee osteoarthritis by comparing it to a placebo.
-
Which antibiotic works best for kids with sinus infections?
This study tests whether amoxicillin, amoxicillin-clavulanate, or a placebo help children with acute sinusitis feel better faster.
-
Comparing Antibiotics and Placebo for Ear Infections in Toddlers
This trial tests whether amoxicillin, amoxicillin-clavulanate, or a placebo help reduce symptoms in children with acute otitis media.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.